Blood Safety (HCV)

FDA Delays Warning Blood Recipients of Potential HCV Contamination

Published in Hepatitis Weekly, October 19th, 1998

According to an October 7, 1998, CNN news report, U.S. Congressman Christopher Shays (R-CT) accused the U.S. Food and Drug Administration of "dragging its feet" over notifying certain blood transfusion recipients about their potential exposure to the hepatitis C virus.

Shays claimed a series of delays has given the corporate entities involved time to prepare for a FDA look-back which would identify donors infected with the virus who gave blood prior to July 1992. The FDA would then notify recipients of this potentially tainted blood about their risk of acquiring hepatitis C.

According to the CNN report, by Louise Schiavone, "the head of the FDA's...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1998-10-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry